Tirzepatide body-composition DXA substudy pooled SURMOUNT-1, about 75:25 fat-to-lean loss, visceral fat about -40%: Look DOM 2024
Clarifying these factors is essential for future trial design, the optimization of inclusion criteria, and the identification of the clinical phenotypes and healthcare settings most likely to benefit from GCSF therapy
Additional research is exploring its utility in examining selective senescent cell vulnerability, apoptosis signaling mechanisms, and the molecular regulation of cell survival under chronic stress conditions
The peptide would hit your stomach acid and get broken down before it could be absorbed
A2A receptor activation upregulates vascular endothelial growth factor (VEGF), promotes angiogenesis in the dermal microvasculature, stimulates fibroblast migration and proliferation, and suppresses inflammatory cytokine release
Kawai et al., 1993